Signature Resources Capital Management LLC Reduces Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Signature Resources Capital Management LLC cut its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 6.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 333 shares of the biotechnology company’s stock after selling 23 shares during the quarter. Signature Resources Capital Management LLC’s holdings in Axon Enterprise were worth $198,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Quent Capital LLC grew its stake in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC grew its position in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Axon Enterprise by 4,750.0% in the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after buying an additional 95 shares during the last quarter. Brooklyn Investment Group acquired a new stake in Axon Enterprise in the third quarter valued at $41,000. Finally, Planning Capital Management Corp raised its holdings in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last three months. 5.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on AXON shares. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. JMP Securities boosted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Finally, Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Stock Performance

AXON opened at $593.89 on Tuesday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $616.92 and its 200-day moving average is $463.24. The stock has a market cap of $45.28 billion, a PE ratio of 153.46, a price-to-earnings-growth ratio of 5.95 and a beta of 1.04. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.